Naicons

Stefano Donadio – Chief Executive Officer

Stefano has over 25 years of industrial experience with antibiotics and natural products. Before founding Naicons, Stefano was among the founders of Biosearch Italia, the company that discovered dalbavancin, where he was VP of Microbial Technologies and part of the Board of Directors. Previously, he was a scientist at Lepetit and Abbott Labs. He has made important contributions to the discovery of novel antibiotics, to the development of production processes and to devising technologies for natural products, as documented by over 120 publications and patent applications. After a degree in biochemistry from the University of Naples, Italy, he did postdoctoral work at John Hopkins University and the University of Wisconsin-Madison.   Personal profile.

 

Marianna Iorio – Post- Doctoral Researcher

Marianna studied Pharmaceutical Chemistry and Technologies at University of Naples, Italy, and received her Ph.D. in Agrochemistry in 2008. During her Ph.D. period she spent one year at University of Massachusetts, USA, specialising in nanoparticles for environmental application. She was awarded a postdoctoral fellowship at the National Research Council in Milan, Italy, where she started collaborating with Naicons and deepening anti-infective compounds. She is currently employed at Naicons srl, working on structure elucidation of novel bioactive molecules.

 

 

 


 This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 720793